SABS

Conviction 51HealthcareScan · Mon, Aug 10, 2026

SABS$3.79-2.82%

ResistanceSupportVol 14

Vol MA14 602.75K

May 11May 28Jun 16Jul 6Jul 23Aug 10

SAB Biotherapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.sab.bio ↗

Price3.79

Change-2.82%

Gap-1.03%

Rel volume3.67×

Avg volume578.26K

Avg $ vol2.12M

SMA 203.63

SMA 503.67

SMA 2003.76

Price vs 50+3.19%

Price vs 200+0.71%

MA stackmixed

50/200 cross—

Supertrendup · 3.32

RSI (14)54

MACD hist0.04

MACD crossbull · 5d

Stoch %K / %D71 / 80

ADX (14)14

+DI / −DI23 / 18

RSI divergence—

MACD divergenceBullish

ATR %+5.11%

ADR %4.83%

52w high4.59

52w low1.95

From 52w high-17.43%

Above 52w low+94.36%

New 52w highNo

SqueezeOff

Bollinger width15.24%

%B0.78

Donchian pos70.97%

Donchian high3.97

Donchian low3.35

AVWAP (52w high)3.85

vs AVWAP high-1.48%

AVWAP (52w low)3.77

vs AVWAP low+0.46%

OBV trendFlat

Chaikin MF (20)-0.12

Today vs 20d3.67×

Avg vol (14d)602.75K

Avg vol (20d)578.26K

Avg $ vol (20d)2.12M

Market cap344.84M

RS 3m (vs SPY)-10.34%

RS 6m (vs SPY)-16.12%

RS line new highNo

Trend template5/8

Technical rank42.7

1 week+0.00%

1 month-0.79%

3 months-7.79%

6 months-9.11%

1 year+69.96%

YTD+0.53%

P/E25.98

P/B1.61

P/S—

P/FCF-7.54

EPS-0.7900

Div yield—

ROE6.18%

ROA5.57%

Debt/Eq—

Current9.22

EV/EBITDA-7.32

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth138.92%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value336.57M

Revenue263.14K

Net income-22.49M

Gross profit—

Free cash flow-45.71M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out76.46M

Employees86

ListedFri, Oct 22, 2021

Free float47.12M

Float %92.5%

Short interest4.38M

Days to cover9.4d

Short volume53.2%

Squeeze score67 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction51 / 100

Pattern quality—

Tech rank42.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.09

Support3.41

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SABS

All disclosures →

No recent disclosed trades by Congress in SABS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SABS

No recent insider (Form 4) filings in SABS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SABS · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.